Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma
Shah, Nina, Mojebi, Ali, Ayers, Dieter, Cope, Shannon, Dhanasiri, Sujith, Davies, Faith E, Hari, Parameswaran, Patel, Payal, Hege, Kristen, Dhanda, Devender
Published in Journal of comparative effectiveness research (01.07.2022)
Published in Journal of comparative effectiveness research (01.07.2022)
Get full text
Journal Article
P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI‐CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Abonour, Rafat, Rifkin, Robert, Ailawadhi, Sikander, Lee, Hans C., Gasparetto, Christina, Wagner, Lynne, Durie, Brian, Hardin, James, Terebelo, Howard, Narang, Mohit, Toomey, Kathleen, Tang, Yuexin, Dhanasiri, Sujith, Anand, Jasmeet, Yu, Edward, Marshall, Thomas, Liu, Liang, Jagannath, Sundar
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimens
Zamagni, Elena, Dhanasiri, Sujith, Ghale, Arun, Moore, Adam, Roussel, Murielle
Published in Leukemia & lymphoma (24.08.2021)
Published in Leukemia & lymphoma (24.08.2021)
Get full text
Journal Article
Patient Characteristics, Treatment Outcomes and Healthcare Resource Utilization across Europe in Multiple Myeloma Patients Ineligible for Stem Cell Transplantation Who Received Lenalidomide- or Bortezomib-Based Regimens
Zamagni, Elena, Dhanasiri, Sujith, Moore, Adam, Ghale, Arun, Roussel, Murielle
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Treatment Patterns and Outcomes for Patients with Newly Diagnosed Multiple Myeloma Post-Stem Cell Transplantation Who Received Lenalidomide As First Line Maintenance Therapy (PREAMBLE)
Vij, Ravi, Amin, Suvina, Gu, Jin, Marshall, Thomas S., Fish, Susan, Dhanasiri, Sujith, Hernandez, Gabriela, Cella, David, Goldschmidt, Hartmut, Ramasamy, Karthik
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Lenalidomide Maintenance Therapy Post-Autologous Stem Cell Transplant: A Healthcare Cost-Impact Analysis in Europe
Jackson, Graham, Dutton, Richard, Zamagni, Elena, Hughes, Rowena, Dhanasiri, Sujith
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Safety and Survival Outcomes in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-Based or Non-Lenalidomide-Based Treatments in the Real-World MM-034 Study
Cavo, Michele, Dhanasiri, Sujith, De Stefano, Valerio, Ramírez Payer, Angel, Wiesholzer, Martin, Tromp, Yvonne, Perera, Meegahage Ratnakanthi, Richez-Olivier, Valentine, Gil, Maciej, Bernasconi, David, Gamberi, Barbara
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure
Ramasamy, Karthik, Abildgaard, Niels, Vekemans, Marie-Christiane, Gamberi, Barbara, Ramírez Payer, Angel, Millar, Gillian, Ansaloni, Annalisa, Atiba-Davies, Margaret, Bernasconi, David, Plesner, Torben, Dhanasiri, Sujith
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Health-Related Quality of Life (HRQoL) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Who Are Triple-Class Exposed to an Immunomodulatory Agent, a Proteasome Inhibitor, and an Anti-CD38 Antibody
Shah, Nina, Vij, Ravi, Roberts, Jenna S., Rajkovic, Ivana, Silbermann, Rebecca, Hillengass, Jens, Dhanasiri, Sujith, Braverman, Julia, McMillan, Abigail, Dhanda, Devender
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study
Dhanasiri, Sujith, Hollier-Hann, Georgia, Stothard, Catherine, Dhanda, Devender S., Davies, Faith E., Rodriguez-Otero, Paula
Published in Clinical therapeutics (01.11.2021)
Published in Clinical therapeutics (01.11.2021)
Get full text
Journal Article
Efficacy of Pomalidomide, Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma Post-Lenalidomide: Results from a Systematic Literature Review and Indirect Treatment Comparison
Weisel, Katja C., Dhanasiri, Sujith, Gauthier, Aline, Padhiar, Amie, Casal, Eva, Richardson, Paul G.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Pomalidomide, bortezomib, and dexamethasone in lenalidomide-pretreated multiple myeloma: A subanalysis of OPTIMISMM by frailty
Oriol Rocafiguera, Albert, Dimopoulos, Meletios A., Schjesvold, Fredrik, Beksac, Meral, Yagci, Münci, Larocca, Alessandra, Guo, Shien, Mu, Yutian, Hong, Kevin, Dhanasiri, Sujith, Richardson, Paul G., Weisel, Katja
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide Exposure
Davies, Faith E., Leleu, Xavier, Vogel, Prisca, Dhanasiri, Sujith, Le Nouveau, Pauline, Weisel, Katja
Published in Clinical lymphoma, myeloma and leukemia (01.11.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.11.2023)
Get full text
Journal Article
Lenalidomide As Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplantation: A Pharmacoeconomic Assessment in the Netherlands
Uyl-de Groot, Carin A., Ramsden, Rachel, Boersma, Janneke, Zweegman, Sonja, Dhanasiri, Sujith
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Lenalidomide Plus Bortezomib and Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma: Results from a Canadian Cost-Effectiveness Analysis
Sebag, Michael, Stakiw, Julie, Stephens, Thomas J., Padhiar, Amie, Kim, Tony, Shum, Jane, Dhanasiri, Sujith, Trudel, Suzanne
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
A Matching-Adjusted Indirect Comparison of Efficacy Outcomes for Idecabtagene Vicleucel (ide-cel, bb2121), a Bcma-Directed CAR T Cell Therapy Versus Conventional Care in Triple-Class-Exposed Relapsed and Refractory Multiple Myeloma
Shah, Nina, Ayers, Dieter, Davies, Faith E., Cope, Shannon, Mojebi, Ali, Parikh, Kejal, Dhanda, Devender, Hari, Parameswaran, Patel, Payal, Huang, Liping, Hege, Kristen, Dhanasiri, Sujith
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article